TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT06323356 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-22 → 2026-07-10 3. primary completion date: 2025-10-15 → 2025-10-17
Clinical trial NCT06323356 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-22 → 2026-07-10 3. primary completion date: 2025-10-15 → 2025-10-17
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical